Systematic Review and Economic Evaluation of a Long-Acting Insulin Analogue, Insulin Glargine

Health Technology Assessment- United Kingdom

doi 10.3310/hta8450

Full Text

Abstract

Available in

Date

Authors

Publisher

National Institute for Health Research

Related search

Long Acting Insulin Glargine Overdose, a Surprising Long Lifetime

Toxicology Communications
2019English

Pdb11 - Chart Review Analysis of Insulin Glargine 300 and Insulin Glargine 100 Use in France, Spain, and Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2016English

Evaluation of Dosing and Clinical Outcomes in Patients Undergoing Conversion of Insulin Glargine to Insulin Detemir

Pharmacotherapy
Pharmacology
2013English

Effects of the Long-Acting Somatostatin Analogue Lanreotide Autogel on Glucose Tolerance and Insulin Resistance in Acromegaly

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2006English

Long-Acting Insulin: Slow Release of Insulin From a Biodegradable Matrix Implanted in Diabetic Rats

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
1983English

Insulin Toujeo® — A Novel Basal Long-Acting Insulin Formulation. Part 2. Clinical Efficacy and Safety

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2016English

Real World Outcomes of Adding Rapid-Acting Insulin Versus Switching to Analog Premix Insulin Among US Patients With Type 2 Diabetes Treated With Insulin Glargine

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2013English

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-Long-Acting Basal Insulin

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy